Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment

被引：0
作者：
Arefeh Basiri
Fatemeh Mansouri
Arezo Azari
Parviz Ranjbarvan
Fateme Zarein
Arash Heidari
Ali Golchin
机构：
[1] Isfahan University of Medical Sciences,Department of Biomaterials and Tissue Engineering, School of Advanced Technologies in Medicine
[2] Universal Scientific Education and Research Network (USERN),Regenerative Medicine Group (REMED)
[3] Urmia University of Medical Sciences,Department of Genetics and Immunology, Faculty of Medicine
[4] Urmia University of Medical Sciences,Cellular and Molecular Research Center
[5] Shahid Beheshti University of Medical Sciences,Department of Tissue engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine
[6] Urmia University of Medical Sciences,Department of Clinical Biochemistry and Applied Cell Sciences, Faculty of Medicine
[7] Tarbiat Modares University,Department of Nanobiotechnology, faculty of biological sciences
[8] Tehran University of Medical Sciences,School of Medicine
来源：
Stem Cell Reviews and Reports | 2021年 / 17卷
关键词：
COVID-19; Personalized medicine; Cell-based therapy; Stem cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 213
页数：20
相关论文
共 667 条
[31]  
Boelens JJ(2020)Estimates of the severity of coronavirus disease 2019: A model-based analysis The Lancet Infectious Diseases 20 669-888
[32]  
Hanley PJ(2003)Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 450-14
[33]  
Lafond KE(2020)Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients British Journal of Haematology 189 428-5052
[34]  
Nair H(2018)Cytokine release syndrome Journal for ImmunoTherapy of Cancer. BioMed Central Ltd. 6 56-982
[35]  
Rasooly MH(2020)Clinical and immunological features of severe and moderate coronavirus disease 2019 Journal of Clinical Investigation 130 2620-38
[36]  
Valente F(2020)Sickle cell trait and the potential risk of severe coronavirus disease 2019– A mini-review European Journal of Haematology. 105 519-918
[37]  
Booy R(2020)A precision medicine approach to managing 2019 novel coronavirus pneumonia Precision Clinical Medicine 3 14-1203
[38]  
Rahman M(2019)Natural killer cells in sepsis: Underprivileged innate immune cells European Journal of Cell Biology. Elsevier GmbH. 98 81-12
[39]  
Petersen E(2016)Harnessing NK cell memory for Cancer Immunotherapy Trends in Immunology. Elsevier Ltd. 37 877-754
[40]  
Koopmans M(2018)Cardiosphere-derived cells suppress allogeneic lymphocytes by production of PGE2 acting via the EP4 receptor Scientific Reports 8 1-1316
12345678910